相关实验视频
Updated: Jan 16, 2026

Glutamine Flux Imaging Using Genetically Encoded Sensors
Published on: July 31, 2014
谷氨胺代谢和氨死亡:针对性调节以增强癌症免疫疗法
Fei Du1,2, Linlin Xiao1, Wang Guojun1
1Department of Pharmacy, The Fourth Affiliated Hospital of Southwest Medical University, Meishan, Sichuan, China.
氨在T细胞中的积累可以触发一种新的细胞死亡途径,增强抗瘤免疫力. 针对这种"氨死亡"可能会改善癌症免疫疗法对目前治疗耐药的患者的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢途径 代谢途径
背景情况:
- 免疫疗法,包括免疫检查点抑制剂 (ICI) 和仿真抗原受体 (CAR) -T细胞,对于癌症治疗至关重要,但面临患者反应异质性和免疫逃避的挑战.
- 细胞死亡机制越来越被认为是通过放大抗瘤免疫反应来优化免疫治疗的关键.
- 瘤微环境 (TME) 中的一种代谢副产品氨,由于谷氨胺代谢而在效应T细胞中积累,导致一种新的细胞死亡形式.
研究的目的:
- 审查谷氨胺在TME细胞中的代谢作用.
- 探索谷氨胺代谢和氨酸诱导的细胞死亡之间的联系.
- 评估向氨诱导的细胞死亡,以增强抗瘤免疫力和改善免疫治疗.
主要方法:
- 文献综述侧重于TME内的谷氨胺代谢,氨积累和细胞死亡途径.
- 对氨诱导细胞死亡及其独特机制的新兴研究进行分析.
- 针对氨诱导细胞死亡的治疗策略的评估,以增强免疫治疗.
主要成果:
- 谷氨胺代谢显著影响各种TME细胞.
- 由谷氨胺代谢驱动的T细胞中氨的积累,诱导了一种独特的细胞死亡途径,称为"氨死亡".
- 这种氨死机制不同于之前识别的细胞死亡过程.
结论:
- 准氨诱导的细胞死亡是克服免疫疗法耐药性的有希望的策略.
- 操纵谷氨胺代谢和氨水平可以增强抗瘤免疫反应.
- 对氨死亡的进一步研究有可能改善癌症免疫治疗的临床结果.
更多相关视频
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
09:04Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Inorganic Nitrogen Assimilation
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...